The International Journal of Tuberculosis and Lung Disease

On the predictability of the tuberculosis epidemic [Editorial]
pp. 711-712(2)
Author: Rieder, Hans L.

Preventing tuberculosis with silica dust controls [Editorial]
pp. 713-714(2)
Authors: Gottesfeld, Perry; Murray, Jill; Chadha, Sarabjit S.; Rees, David

The role of health economics research in implementation research for health systems strengthening [State of the art series. Operational research. Number 6 in the series]
pp. 715-721(7)
Authors: Mann, G. H.; Thomson, R.; Jin, C.; Phiri, M.; Vater, M. C.; Sinanovic, E.; Squire, S. B.

Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV/AIDS era: a systematic review [Review article]
pp. 722-728(7)
Authors: van der Watt, J. J.; Harrison, T. B.; Benatar, M.; Heckmann, J. M.

Transthoracic lung aspiration for the aetiological diagnosis of pneumonia: 25 years of experience from The Gambia [Review article]
pp. 729-735(7)
Authors: Ideh, R. C.; Howie, S. R. C.; Ebruke, B.; Secka, O.; Greenwood, B. M.; Adegbola, R. A.; Corrah, T.

Long-term course of Mycobacterium tuberculosis infection in Swedish birth cohorts during the twentieth century
pp. 736-740(5)
Authors: Winqvist, N.; Björk, J.; Miörner, H.; Björkman, P.

Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis
pp. 741-745(5)
Authors: Nunn, A. J.; Jindani, A.; Enarson, D. A.; Study A investigators

Implications of the current tuberculosis treatment landscape for future regimen change
pp. 746-753(8)
Authors: Wells, W. A.; Konduri, N.; Chen, C.; Lee, D.; Ignatius, H. R.; Gardiner, E.; Schwalbe, N. R.

Treatment interruptions and inconsistent supply of anti-tuberculosis drugs in the United Kingdom
pp. 754-760(7)
Authors: Capstick, T. G. D.; Laycock, D.; Lipman, M. C. I.; UK Coalition to Stop TB

Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol
pp. 761-766(6)
Authors: Lowenthal, P.; Westenhouse, J.; Moore, M.; Posey, D. L.; Watt, J. P.; Flood, J.

Absence of interferon-gamma release assay conversion following tuberculin skin testing
pp. 767-769(3)
Authors: Ritz, N.; Yau, C.; Connell, T. G.; Tebruegge, M.; Leslie, D.; Curtis, N.

Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival
pp. 770-775(6)
Authors: Wiseman, C. A.; Schaaf, H. S.; Cotton, M. F.; Gie, R. P.; Jennings, T.; Whitelaw, A.; Roux, P.; Hesseling, A. C.

Tuberculosis may be underestimated in Rwandan women
pp. 776-781(6)
Authors: Uwizeye, C. B.; De Serres, G.; Gilca, R.; Schwartzman, K.; Gasana, M.

Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases
pp. 782-788(7)
Author: Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India

Genotyping and drug resistance patterns of Mycobacterium tuberculosis strains in five provinces of China
pp. 789-794(6)
Authors: Guo, Y-L.; Liu, Y.; Wang, S-M.; Li, C-Y.; Jiang, G-L.; Shi, G-L.; Song, C-X.

Detection of tuberculosis using artus® M. tuberculosis PCR Kit and COBAS® AMPLICOR™ Mycobacterium tuberculosis Test
pp. 795-798(4)
Authors: Hur, M.; Moon, H-W.; Yun, Y-M.; Kang, T. Y.; Kim, H-S.; Kim, H. S.; Lee, K. M.; Kang, S-H.; Lee, E-H.

Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis
pp. 799-803(5)
Authors: Tho, D. Q.; Lan, N. T. N.; Chau, N. V. V.; Farrar, J.; Caws, M.

Novel monoclonal antibodies to ESAT-6 and CFP-10 antigens for ELISA-based diagnosis of pleural tuberculosis
pp. 804-810(7)
Authors: Feng, T-T.; Shou, C-M.; Shen, L.; Qian, Y.; Wu, Z-G.; Fan, J.; Zhang, Y-Z.; Tang, Y-W.; Wu, N-P.; Lu, H-Z.; Yao, H-P.

Characteristics of skin and soft tissue infection caused by non-tuberculous mycobacteria in Taiwan
pp. 811-817(7)
Authors: Hsiao, C-H.; Tsai, T-F.; Hsueh, P-R.

Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population
pp. 818-823(6)
Authors: Laniado-Laborin, R.; Rendón, A.; Bauerle, O.

Chronic obstructive lung disease–related health care utilisation in Korean adults with obstructive lung disease
pp. 824-829(6)
Authors: Jung, J. Y.; Kang, Y. A.; Park, M. S.; Oh, Y. M.; Park, E. C.; Kim, H. R.; Lee, S. D.; Kim, S. K.; Chang, J.; Kim, Y. S.

Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia
pp. 830-837(8)
Authors: Lee, J. H.; Oh, Y-M.; Seo, J. B.; Lee, Y. K.; Kim, W. J.; Sheen, S. S.; Kim, T-H.; Lee, J-H.; Kim, E-K.; Lee, J. S.; Huh, J. W.; Lim, S. Y.; Yoon, H. I.; Shin, T. R.; Lee, S-M.; Lee, S. Y.; Lee, S-D.

Association between smoking status, other factors and tuberculosis treatment failure in Morocco
pp. 838-843(6)
Authors: Tachfouti, N.; Nejjari, C.; Benjelloun, M. C.; Berraho, M.; Elfakir, S.; El Rhazi, K.; Slama, K.

Waterpipe tobacco use among Iranian university students: correlates and perceived reasons for use
pp. 844-847(4)
Authors: Sabahy, A-R.; Divsalar, K.; Bahreinifar, S.; Marzban, M.; Nakhaee, N.

Decline in tuberculosis with 19 years of universal directly observed therapy in a comprehensive statewide program [Notes from the field]
pp. 848-850(3)
Authors: Webb, R. M.; Penman, A.; Holcombe, M.; Dobbs, T.; Mathew, T. A.

‘Universal’ access for MDR-TB limited without the involvement of the private sector [Correspondence]
pp. 851-851(1)
Authors: Pinto, Lancelot; Udwadia, Zarir

In reply to ‘“Universal” access for MDR-TB limited without the involvement of the private sector’ [Correspondence]
pp. 851-852(2)
Authors: Keshavjee, Salmaan; Farmer, Paul

Erratum
pp. 852-852(1)